Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $18.50M.
ENTERPRISE VALUE (EV)
$18.50M
aTyr Pharma, Inc.
Market Cap
$27.78M
Enterprise Value (EV)
$18.50M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| aTyr Pharma, Inc. (ATYR) | $27.78M | $18.50M |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.60M | $68.65M |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $28.86M | $30.82M |
| OneMedNet Corporation (ONMD)vs › | $29.10M | $29.45M |
| Quantum Cyber N.V. (QUCY)vs › | $29.48M | $16.28M |
| Context Therapeutics Inc. (CNTX)vs › | $29.53M | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $30.16M | $30.60M |
| iTonic Holdings Ltd. (ITOC)vs › | $25.72M | $25.18M |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.37M | $26.76M |
| CervoMed Inc. (CRVO)vs › | $30.38M | $7.92M |
Market Cap
$27.78M
Total Debt
$1.47M
Cash
$10.74M
Enterprise Value
$18.50M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
